Social Wire

Newsroom RSS

Press Releases
Social Wire

Press Contact

Ross Director of Public Relations

pr@longevitybiotech.com
215-689-1042

About Longevity Biotech, Inc

Visit Website

View Newsroom

Longevity Biotech is a leading biotech company developing a new class of therapeutic compounds called Hybridtides®.

Learn More »

Address

Longevity Biotech, Inc

3025 Market Street (Suite 140)

Philadelphia, PA 19104

United States

215-689-1042

Follow +

Posted Oct 25, 2018 We are back on the road ✈️again this week. NYC-bound to attend both the The Michael J. Fox Foundation for Parkinson's Research Therapeutics Conference and the Galien MedStartup Conference Stay tuned to see where we will be next week!

Tweeted Oct 25, 2018

Longevity Biotech
@LongevityBio We are back on the road 🚂🚙✈️🛴again this week. NYC-bound to attend both the @MichaelJFoxOrg for Parkinson's Research… https://t.co/meOVP0KM5n

Tweeted Oct 16, 2018

Longevity Biotech
@LongevityBio We are on the road again this week! Looking forward to attending the @Breakout_Labs Unboxing later this week.… https://t.co/n8141OcRrZ

Posted Oct 16, 2018 We are on the road again this week! Looking forward to attending the Breakout Labs Unboxing later this week. Contact us if you would like to schedule a meeting while we are in town.

Tweeted Oct 11, 2018

Longevity Biotech
@LongevityBio Great post... Looking forward to our Longevity panel discussion this afternoon at the @LSXLeaders conference w/… https://t.co/m8ZBDgaGPQ

Posted Oct 9, 2018 In Boston for a few days for meetings and conferences. Send a msg if you are interested in learning more about Longevity Biotech and what we are working on!

Posted Oct 2, 2018 Exciting day of Parkinson's disease therapeutics discussion here at MJFF. Some very interesting work, lots of development. #inflammation #immuneBalance.

Posted Aug 2, 2018 Team outing at the Phillies game!

Posted Jul 20, 2018 Wanna learn more about what we are working on in terms of neuroscience? Listen to this great webinar to learn more about the role of the immune system in neurodegeneration and Parkinson's disease. Then ask us about how LBT-3627 may help.

Posted Jul 16, 2018 Proud to announce the launch of clinical activities towards Parkinson's disease immunological biomarker identification with a goal of identification and stratification by a blood test. Also, we will be evaluating therapeutic potential of LBT-3627 on patient immune cells.

Posted Jul 15, 2018 Happy National Ice Cream Day from the Longevity Biotech team!

Posted Jun 18, 2018 Welcome to the team Sarah! Excited to have you join and looking forward to clinical activities soon...

Posted Apr 28, 2018 Great day for the Philadelphia Science Festival....

Press Releases	Instant	Daily	Never
News	Instant	Daily	Never
Event	Instant	Daily	Never
Blog		Daily	Never
Facebook		Daily	Never
Twitter		Daily	Never